Pediatric Hematology and Oncology

Papers
(The TQCC of Pediatric Hematology and Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicity21
COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas18
Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study16
Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial13
COVID19 in children with cancer in low- and middle-income countries: Experience from a cancer center in Chennai, India13
Efficacy and safety of eltrombopag in the first-line therapy of severe aplastic anemia in children13
Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia11
Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas10
Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma10
COVID-19 reinfection in two children with cancer9
Clinical variability in multifocal lymphangioendotheliomatosis with thrombocytopenia: a review of the literature8
Outcomes of blinatumomab based therapy in children with relapsed, persistent, or refractory acute lymphoblastic leukemia: a multicenter study focusing on predictors of response and post-treatment immu7
Efficacy and safety of vemurafenib in Langerhans cell histiocytosis (LCH): A systematic review and meta-analysis7
The clinicopathological profile and value of multidisciplinary management of pediatric brain tumors in a low-income setting7
Current status of African pediatric oncology education efforts aligned with the Global Initiative for Childhood Cancer7
Intravenous anakinra for tisagenlecleucel-related toxicities in children and young adults7
Association of body mass index with toxicity and survival in pediatric patients treated with cisplatin-containing regimens7
Secondary hemophagocytic lymphohystiocytosis in a Rubinstein Taybi syndrome patient6
Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) – a case series6
Traumatic lumbar punctures in diagnostic and intrathecal treatment punctures of pediatric hemato-oncology patients6
Outcome and prognostic factors in childhood B non-Hodgkin lymphoma from India: Report by the Indian Pediatric Oncology Group (InPOG-NHL-16-01 study)6
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children’s oncology group report6
Weight status and health behaviors of adolescents and young adults with sickle cell disease: The emerging risk for obesity6
Survival in patients with high-risk neuroblastoma treated without autologous stem cell transplant or dinutuximab beta6
Breakthrough bleeding episodes in pediatric severe hemophilia a patients with and without inhibitors receiving emicizumab prophylaxis: a single-center retrospective review6
Arsenic trioxide in pediatric cancer – a case series and review of literature6
ABCC4, ITPA, NUDT15, TPMT and their interaction as genetic predictors of 6-mercaptopurine intolerance in chinese patients with acute lymphoblastic leukemia6
Treatment of infantile fibrosarcoma associated to an abdominal aortic aneurysm with larotrectinib: a case report5
Heterozygous CTLA4 splice site mutation c.458-1G > C presenting with immunodeficiency and variable degree of immune dysregulation in three generation kindred of Caribbean descent5
High grade gliomas in young children: The South Thames Neuro-Oncology unit experience and recent advances in molecular biology and targeted therapies5
Superficial CD34-Positive Fibroblastic Tumor on the Chest Wall of an 8-Year-Old Girl: A Case Report and Literature Review5
The effects of NUDT15 and TPMT variants on mercaptopurine treatment in Vietnamese pediatric acute lymphoblastic leukemia patients5
The announcement of treatment resistance from the pediatric oncologist’s point of view: a qualitative study5
Outcomes of pediatric mixed phenotype acute leukemia treated with lymphoid directed therapy: Analysis of an institutional series from India5
Evaluating the baseline survival outcomes of the “six Global Initiative for Childhood Cancer index cancers” in Africa5
When to suspect GATA2 deficiency in pediatric patients: from complete blood count to diagnosis5
Clinical Characteristics and Outcomes of 101 Children with Hemophagocytic Lymphohistiocytosis: A Four-Year Single-Center Experience from Egypt5
Study of the diagnostic criteria for hemophagocytic lymphohistiocytosis in neonatal and pediatric patients with severe sepsis or septic shock4
Seasonal variation of respiratory viral infections: a comparative study between children with cancer undergoing chemotherapy and children without cancer4
Changes in anthropometrical status and body composition in children with cancer during initial chemotherapy4
Impact of minimal residual disease on relapse in childhood acute lymphoblastic leukemia: Lessons learnt from a tertiary cancer center in India4
Accuracy of online medical information: the case of social media in sickle cell disease4
Familial hemophagocytic lymphohistiocytosis induced by SARS-CoV-24
Clinical characteristics and successful treatment outcomes of children and adolescents with Kaposi sarcoma in Southwestern Tanzania4
Combined immunodeficiency with marginal zone lymphoma due to a novel homozygous mutation inIL-21Rgene and successful treatment with hematopoietic stem cell transplantation4
Early mortality continues to be a barrier to excellent survival in childhood acute promyelocytic leukemia: a retrospective study of 62 patients spanning 17 years4
Late effects care for childhood brain Tumor Survivors: A Quality-Improvement Initiative4
Glucocorticoid resistance induced by ANXA5 overexpression in B-cell acute lymphoblastic leukemia4
Clinical characteristics and outcomes of combined thrombolysis and anticoagulation for pediatric and young adult lower extremity and inferior vena cava thrombosis4
PASTEC - a prospective, single-center, randomized, cross-over trial of pure physical versus physical plus attentional training in children with cancer4
Prevalence of the BRAF V600E mutation in Greek adults with Langerhans cell histiocytosis4
MicroRNA-199a deficiency relates to higher bone marrow blasts, poor risk stratification and worse prognostication in pediatric acute myeloid leukemia patients4
Impact of the COVID-19 pandemic on health-related quality of life and anxiety in pediatric hematology/oncology patients4
Incidence and Risk Factors of Venous Thromboembolism in Childhood Acute Lymphoblastic Leukaemia – a Population-Based Analysis of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group4
KIF11 as a potential cancer prognostic marker promotes tumorigenesis in children with Wilms tumor3
Gross motor disorders in pediatric patients with acute lymphoblastic leukemia and survivors: A systematic review3
How to recognize inborn errors of immunity in a child presenting with a malignancy: guidelines for the pediatric hemato-oncologist3
Association between in-line filtration and Type I hypersensitivity reactions in pediatric oncology patients receiving intravenous etoposide3
Heart rate response and chronotropic incompetence during cardiopulmonary exercise testing in childhood acute lymphoblastic leukemia survivors3
Clinical Profile and Outcomes of Primary Immunodeficiency and Malignancy in Childhood at a Tertiary Oncology Center in Developing Country3
Fertility preservation education for pediatric hematology-oncology fellows, faculty and advanced practice providers: a pilot study3
Prevalence and Risk Factors for Pulmonary Embolism in Pediatric Sickle Cell Disease: A National Administrative Database Study3
Toward 2030: SIOP Africa adopts the Global Initiative for Childhood Cancer3
Hereditary red blood cell membrane defects. Detection of PIEZO1 mutations associated with SPTA1 mutations. An unusual clinical case of hereditary xerocytosis3
Global caregiver concerns of SARS-CoV-2 vaccination in children with cancer: a cross-sectional mixed-methods study3
Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults wi3
Nodular lymphocyte predominant Hodgkin lymphoma: Experience of Polish Pediatric Leukemia/Lymphoma Study Group3
Analysis of survival rates and prognosis of hepatoblastoma in children: a retrospective study from a single center in China3
Usefulness of functional splicing analysis to confirm precise disease pathogenesis in Diamond-Blackfan anemia caused by intronic variants in RPS193
Complete and durable response to immune checkpoint inhibitor in a patient with refractory and metastatic hepatoblastoma3
Hemophagocytic lymphohistiocytosis associated with parvovirus B19-induced aplastic crisis in a hereditary spherocytosis patient: A case report and literature review3
Safety and efficacy of deferasirox in patients with transfusion-dependent thalassemia: A 4-year single-center experience3
Retrospective single-center experience with OEPA/COPDAC and PET-CT based strategy for pediatric Hodgkin lymphoma in a LMIC setting3
Clinical practice guidelines on management of infantile hemangioma: a systematic quality appraisal using the AGREE II instrument3
Retrospective analysis of predisposing factors for difficult lumbar punctures requiring image guidance in pediatric oncology patients3
Clinical profile, outcome and challenges in the management of pediatric Burkitt lymphoma: a single center experience3
Outcome and complications of pediatric acute promyelocytic leukemia in Bangladesh3
TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia3
A brief review of the current knowledge on environmental toxicants and risk of pediatric cancers3
0.030852079391479